Abstract
Thrombotic microangiopathy is one of the complications of bone marrow transplantation and is related to other complications such as graft-versus-host disease, veno-occlusive disease, diffuse alveolar hemorrhage, and cytomegalovirus infection. Thrombotic microangiopathy occurred in three out of 12 patients who underwent allogeneic bone marrow transplantation over the past 1 year at our department. We compared the changes in cytokines and other molecules between patients with and without microangiopathy from before conditioning to the early post-transplantation period. All three patients with microangiopathy showed a significant increase of interleukin-12 at the time of leukocyte recovery after transplantation (two-way layout analysis of variance; P < 0.05), while none of the patients without microangiopathy showed an increase of interleukin-12. no significant differences were found between the two groups with respect to the other cytokines and molecules that were tested. these findings suggested that thrombotic microangiopathy might be predicted at an early stage after bone marrow transplantation by detecting an increase of interleukin-12 at the time of leukocyte recovery. the possibility that thrombotic microangiopathy is related to inflammation or autoimmunity was also suggested.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Takatsuka, H., Takemoto, Y., Okamoto, T. et al. Thrombotic microangiopathy following allogeneic bone marrow transplantation. Bone Marrow Transplant 24, 303–306 (1999). https://doi.org/10.1038/sj.bmt.1701890
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1701890
Keywords
This article is cited by
-
Pediatric Onco-Nephrology: Time to Spread the Word-Part II: Long-Term Kidney Outcomes in Survivors of Childhood Malignancy and Malignancy after Kidney Transplant
Pediatric Nephrology (2022)
-
Urinary cytokines after HCT: evidence for renal inflammation in the pathogenesis of proteinuria and kidney disease
Bone Marrow Transplantation (2014)
-
Vascular endothelial growth factor (VEGF) is associated with reduced severity of acute graft-versus-host disease and nonrelapse mortality after allogeneic stem cell transplantation
Bone Marrow Transplantation (2006)
-
Transplant-associated microangiopathy (TAM) in recipients of allogeneic hematopoietic stem cell transplants
Bone Marrow Transplantation (2005)
-
Renal function following hematological stem cell transplantation in childhood
Pediatric Nephrology (2003)